Areas of Interest
B-BIC will select early stage technologies that address unmet medical needs or offer great scientific opportunities with either immediate commercial potential or otherwise present compelling reasons for continued development. B-BIC is currently focused on innovative devices, diagnostics, and therapeutics related to heart, lung, blood, and sleep disorders. Program priority areas include, but are not limited to, the following:
Heart failure, atherothrombosis, myocardial infarction, hypertension, atrial fibrillation along with other atrial and ventricular arrhythmias, sudden cardiac death, adult and pediatric congenital heart disease, cardiovascular complications of diabetes and obesity, acquired valve disease, cardiomyopathies, and peripheral vascular diseases.
Lung Diseases and Sleep Disorders
Asthma, bronchopulmonary dysplasia, chronic obstructive pulmonary disease, cystic fibrosis, respiratory neurobiology, sleep-disordered breathing, critical care and acute lung injury, developmental biology and pediatric pulmonary diseases, immunologic and fibrotic pulmonary disease, rare lung disorders, pulmonary vascular disease, and pulmonary complications of AIDS and tuberculosis.
Blood Diseases and Resources
Sickle cell disease (SCD), the thalassemias, Fanconi anemia, Diamond-Blackfan anemia and other bone marrow failure syndromes, iron metabolism, fetal hemoglobin production, white blood cell disorders, myeloproliferative and myelodysplastic syndromes, hematopoietic stem cell transplantation and novel cell-based therapies, transfusion medicine (red blood cells, platelets, and plasma) and blood banking including technologies to store and process blood, thrombosis and hemostatic disorders including but not limited to idiopathic thrombocytopenic purpura (ITP), thrombotic thrombocytopenic purpura (TTP), hemophilia, and coagulation factor deficiencies and disorders.
All pre-proposals and full proposals must be submitted using the online application system at b-bic.fluidreview.com.
All required supporting documents, including the B-BIC budget form, compliance, form, NIH biosketches, and institutional authorization must be uploaded into the online application system.
All text material must be in a readable font (at least Arial 10 point), and margins must be at least 0.5 inches.
B-BIC is funded by the NIH/NHLBI under award U54HL119145 and through the institutional support provided by our member institutions.